Published in Am J Physiol Endocrinol Metab on January 25, 2005
A systematic review of maternal obesity and breastfeeding intention, initiation and duration. BMC Pregnancy Childbirth (2007) 2.29
Maternal obesity and developmental programming of metabolic disorders in offspring: evidence from animal models. Exp Diabetes Res (2011) 1.43
Role of cholesterol in the development and progression of breast cancer. Am J Pathol (2010) 1.38
Impact of high-fat diet and obesity on energy balance and fuel utilization during the metabolic challenge of lactation. Obesity (Silver Spring) (2011) 0.98
Lactation and neonatal nutrition: defining and refining the critical questions. J Mammary Gland Biol Neoplasia (2012) 0.89
Pubertal high fat diet: effects on mammary cancer development. Breast Cancer Res (2013) 0.87
High fat diet alters lactation outcomes: possible involvement of inflammatory and serotonergic pathways. PLoS One (2012) 0.86
Mammary ductal growth is impaired in mice lacking leptin-dependent signal transducer and activator of transcription 3 signaling. Endocrinology (2010) 0.84
Gender-dependent resiliency to stressful and metabolic challenges following prenatal exposure to high-fat diet in the p66(Shc-/-) mouse. Front Behav Neurosci (2014) 0.83
Reduced breastfeeding rates among obese mothers: a review of contributing factors, clinical considerations and future directions. Int Breastfeed J (2015) 0.83
Does Circadian Disruption Play a Role in the Metabolic-Hormonal Link to Delayed Lactogenesis II? Front Nutr (2015) 0.82
Maternal obesity reduces milk lipid production in lactating mice by inhibiting acetyl-CoA carboxylase and impairing fatty acid synthesis. PLoS One (2014) 0.79
Maternal High-Fat Diet during Pregnancy and Lactation Influences Obestatin and Ghrelin Concentrations in Milk and Plasma of Wistar Rat Dams and Their Offspring. Int J Endocrinol (2016) 0.78
Serotonin Deficiency Rescues Lactation on Day 1 in Mice Fed a High Fat Diet. PLoS One (2016) 0.75
Biological underpinnings of breastfeeding challenges: the role of genetics, diet, and environment on lactation physiology. Am J Physiol Endocrinol Metab (2016) 0.75
Atrophy of S6K1(-/-) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol (2005) 2.80
Prolactin: the new biology of an old hormone. Annu Rev Physiol (2002) 1.82
Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5. Development (2003) 1.79
Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors. Proc Natl Acad Sci U S A (2010) 1.62
Hyperprolactinemia-induced ovarian acyclicity is reversed by kisspeptin administration. J Clin Invest (2012) 1.53
Targeted deletion of the PRL receptor: effects on islet development, insulin production, and glucose tolerance. Endocrinology (2002) 1.52
Impact of a chronic total occlusion in a non-infarct related artery on clinical outcomes following primary percutaneous intervention in acute ST-elevation myocardial infarction. J Invasive Cardiol (2014) 1.42
Development and potential clinical uses of human prolactin receptor antagonists. Endocr Rev (2005) 1.24
Investigation of the transcriptional changes underlying functional defects in the mammary glands of prolactin receptor knockout mice. Recent Prog Horm Res (2003) 1.20
Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem Biophys Res Commun (2005) 1.20
Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms. J Clin Invest (2002) 1.15
Reproductive role of prolactin. Reproduction (2007) 1.13
Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL. J Biol Chem (2007) 1.13
Growth hormone promotes skeletal muscle cell fusion independent of insulin-like growth factor 1 up-regulation. Proc Natl Acad Sci U S A (2006) 1.12
Development of pure prolactin receptor antagonists. J Biol Chem (2003) 1.11
Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors. Proc Natl Acad Sci U S A (2008) 1.10
Effects of deletion of the prolactin receptor on ovarian gene expression. Reprod Biol Endocrinol (2003) 1.10
Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice. Reproduction (2006) 1.10
Structure and regulation of acetyl-CoA carboxylase genes of metazoa. Biochim Biophys Acta (2005) 1.10
The role of prolactin and growth hormone in mammary gland development. Mol Cell Endocrinol (2002) 1.09
Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development (2002) 1.05
Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2. J Biol Chem (2010) 1.04
Prolactin receptor signaling is essential for perinatal brown adipocyte function: a role for insulin-like growth factor-2. PLoS One (2008) 1.02
Growth hormone is required for ovarian follicular growth. Endocrinology (2002) 1.01
High levels of serum prolactin protect against diabetic retinopathy by increasing ocular vasoinhibins. Diabetes (2010) 1.00
Beige differentiation of adipose depots in mice lacking prolactin receptor protects against high-fat-diet-induced obesity. FASEB J (2012) 1.00
Corpus luteum development: lessons from genetic models in mice. Curr Top Dev Biol (2005) 0.98
Growth hormone can act as a cytokine controlling survival and proliferation of immune cells: new insights into signaling pathways. Mol Cell Endocrinol (2002) 0.96
Prolactin signaling through the short form of its receptor represses forkhead transcription factor FOXO3 and its target gene galt causing a severe ovarian defect. Mol Endocrinol (2007) 0.96
Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance. Mol Endocrinol (2004) 0.95
Benign breast diseases. J Mammary Gland Biol Neoplasia (2005) 0.95
Rescue of fertility in homozygous mice for the urokinase plasminogen activator transgene by the transplantation of mouse hepatocytes. Cell Transplant (2008) 0.95
Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology (2004) 0.94
Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest (2013) 0.92
A short form of the prolactin (PRL) receptor is able to rescue mammopoiesis in heterozygous PRL receptor mice. Mol Endocrinol (2003) 0.92
Drug Insight: prolactin-receptor antagonists, a novel approach to treatment of unresolved systemic and local hyperprolactinemia? Nat Clin Pract Endocrinol Metab (2006) 0.91
Developmental aspects of adipose tissue in GH receptor and prolactin receptor gene disrupted mice: site-specific effects upon proliferation, differentiation and hormone sensitivity. J Endocrinol (2006) 0.90
A new mechanism for prolactin processing into 16K PRL by secreted cathepsin D. Mol Endocrinol (2006) 0.90
New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity. Endocrine (2003) 0.88
Effects of growth hormone and prolactin on adipose tissue development and function. Pituitary (2003) 0.87
Novel NOBOX loss-of-function mutations account for 6.2% of cases in a large primary ovarian insufficiency cohort. Hum Mutat (2011) 0.87
Prolactin signaling mechanisms in ovary. Mol Cell Endocrinol (2011) 0.86
Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma. J Endocrinol (2006) 0.86
Rational design of competitive prolactin/growth hormone receptor antagonists. J Mammary Gland Biol Neoplasia (2008) 0.85
Prolactin is not required for the development of severe chronic experimental autoimmune encephalomyelitis. J Immunol (2013) 0.85
Ovarian function is restored after grafting of cryopreserved immature ovary in ewes. FASEB J (2012) 0.85
Prostate development and carcinogenesis in prolactin receptor knockout mice. Endocrinology (2003) 0.85
Prolactin independent rescue of mouse corpus luteum life span: identification of prolactin and luteinizing hormone target genes. Am J Physiol Endocrinol Metab (2009) 0.84
Inhibition of MAPK by prolactin signaling through the short form of its receptor in the ovary and decidua: involvement of a novel phosphatase. J Biol Chem (2011) 0.84
Zero-length cross-linking reveals that tight interactions between the extracellular and transmembrane domains of the luteinizing hormone receptor persist during receptor activation. Mol Endocrinol (2005) 0.83
Immature cryopreserved ovary restores puberty and fertility in mice without alteration of epigenetic marks. PLoS One (2008) 0.83
Asymmetric expression of transcripts derived from the shared promoter between the divergently oriented ACACA and TADA2L genes. Genomics (2005) 0.83
Defective prolactin signaling impairs pancreatic β-cell development during the perinatal period. Am J Physiol Endocrinol Metab (2013) 0.83
Autocrine growth hormone production prevents apoptosis and inhibits differentiation in C2C12 myoblasts. Cell Signal (2003) 0.82
Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation. Endocrinology (2003) 0.82
Regulation of transcription factors and repression of Sp1 by prolactin signaling through the short isoform of its cognate receptor. Endocrinology (2009) 0.82
Should primary percutaneous coronary intervention be the routine reperfusion strategy in octogenarians presenting with ST elevation myocardial infarction? J Cardiovasc Med (Hagerstown) (2014) 0.81
Leptin secretion and hypothalamic neuropeptide and receptor gene expression in sheep. Am J Physiol Regul Integr Comp Physiol (2002) 0.81
The N-terminus of human prolactin modulates its biological properties. Mol Cell Endocrinol (2003) 0.80
The cytoplasmic domain of Mpl receptor transduces exclusive signals in embryonic and fetal hematopoietic cells. Blood (2002) 0.80
Overview of the impact of kisspeptin on reproductive function. Ann Endocrinol (Paris) (2012) 0.80
Growth hormone, acting in part through the insulin-like growth factor axis, rescues developmental, but not metabolic, activity in the mammary gland of mice expressing a single allele of the prolactin receptor. Endocrinology (2002) 0.80
Medullary thyroid carcinoma arises in the absence of prolactin signaling. Cancer Res (2005) 0.80
Decysin, a new member of the metalloproteinase family, is regulated by prolactin and steroids during mouse pregnancy. Biol Reprod (2002) 0.79
New NOBOX mutations identified in a large cohort of women with primary ovarian insufficiency decrease KIT-L expression. J Clin Endocrinol Metab (2014) 0.78
Characterization of a prolactin-regulated gene in reproductive tissues using the prolactin receptor knockout mouse model. Biol Reprod (2002) 0.78
Jak2 and proteasome activities control the availability of cell surface growth hormone receptors during ligand exposure. Cell Signal (2003) 0.78
Localization of messenger RNAs encoding enzymes associated with malonyl-CoA metabolism in mouse brain. Brain Res Gene Expr Patterns (2002) 0.78
Double Myod and Igf2 inactivation promotes brown adipose tissue development by increasing Prdm16 expression. FASEB J (2012) 0.78
Male reproductive function is not affected in prolactin receptor-deficient mice. Endocrinology (2003) 0.78
Prolactin promotes normal liver growth, survival, and regeneration in rodents: effects on hepatic IL-6, suppressor of cytokine signaling-3, and angiogenesis. Am J Physiol Regul Integr Comp Physiol (2013) 0.78
The hormone prolactin is a novel, endogenous trophic factor able to regulate reactive glia and to limit retinal degeneration. J Neurosci (2014) 0.78
Development of new prolactin analogs acting as pure prolactin receptor antagonists. Pituitary (2003) 0.77
Growth-promoting actions of prolactin, the hormone of lactation. J Pediatr Endocrinol Metab (2002) 0.77
Characterisation of an N-terminal variant of acetyl-CoA carboxylase-alpha: expression in human tissues and evolutionary aspects. Biochim Biophys Acta (2003) 0.77
NOBOX is a key FOXL2 partner involved in ovarian folliculogenesis. J Mol Cell Biol (2014) 0.77
In vivo effects of growth hormone on thymic cells. Ann N Y Acad Sci (2003) 0.77
Sequence variation analysis of the prolactin receptor C-terminal region in women with premature ovarian failure. Fertil Steril (2010) 0.77
Autocrine prolactin as a promotor of mammary tumour growth. J Dairy Res (2005) 0.76
The permissive role of prolactin as a regulator of luteinizing hormone action in the female mouse ovary and extragonadal tumorigenesis. Am J Physiol Endocrinol Metab (2013) 0.76